Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |